Overview
Zhangwei Chen practices in Shanghai, China. Chen is rated as an Advanced expert by MediFind in the treatment of Doxorubicin-Induced Cardiomyopathy. Their top areas of expertise are Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Angioplasty.
Their clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Doxorubicin-Induced Cardiomyopathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cardiomyopathy Due to Anthracyclines
- Coronary Heart Disease
- Doxorubicin-Induced Cardiomyopathy
- Percutaneous Coronary Intervention (PCI)
- Experienced
- AnginaChen isExperienced. Learn about Angina.
- AngioplastyChen isExperienced. Learn about Angioplasty.
- CardiomyopathyChen isExperienced. Learn about Cardiomyopathy.
- Cerebral HypoxiaChen isExperienced. Learn about Cerebral Hypoxia.
- Dilated Cardiomyopathy (DCM)
- Heart AttackChen isExperienced. Learn about Heart Attack.